Alginate based biomaterials for hemostatic applications: Innovations and developments.

Area of Science:

• Biomaterials Science
• Hemostatic Agents
• Emergency Medicine

Background:

• Efficient hemostatic materials are crucial for managing emergency hemorrhage and reducing casualties.
• Current hemostats have limitations including exothermic reactions, poor biocompatibility, and painful removal.
• Developing ideal hemostatic compositions with rapid clotting, biocompatibility, and antimicrobial properties is a significant bioengineering challenge.

Purpose of the Study:

• To review the role of alginate-based composite hemostats in enhancing hemostatic potential.
• To explore various hemostatic agents incorporated with alginate.
• To outline challenges and future research directions for clinical application.

Main Methods:

• Review of existing literature on alginate-based hemostats and composite materials.
• Analysis of different categories of hemostatic agents (inorganic, polymeric, biological, herbal, synthetic drugs) combined with alginate.
• Discussion of challenges and future research avenues.

Main Results:

• Alginate-based hemostats demonstrate excellent biocompatibility (>85% cell viability) and high absorption capacity (>500%).
• Sodium alginate shows inherent hemostatic activity, significantly reducing blood loss compared to controls.
• Composite hemostats incorporating various agents show potential for enhanced hemostatic efficacy.

Conclusions:

• Alginate-based materials are promising for developing advanced hemostats due to their favorable properties.
• Composite hemostats offer a strategy to further improve hemostatic performance.
• Addressing challenges related to clinical trials is essential for future development and application.